1.
JPAD-Journal of Pakistan Association of Dermatologists. 1997; 7: 3-7
in English
| IMEMR
| ID: emr-45100
ABSTRACT
A prospective study of CD4 + T lymphocytes along the course of treatment of 25 HIV-infected patients with active tuberculosis receiving antituberculous drugs was compared with 32 non HIV - infected patients with active tuberculosis, also receiving the same regime of anti tuberculous drugs. The CD4 + T cell among non HIV - infected patients were 525 +/- 415/mm[3] and increased to 675 +/- 378/mm[3] and 902 +/- 267/mm[3] at the third and sixth months of therapy. Among HIV- infected patients, the CD4 + T cell counts were 72 +/- 45/mm[3] and decreased to 50 +/- 25/mm[3] and 42 +/- 20/mm[3] at the third and sixth months of therapy [P < 0.05]
Subject(s)
Humans , Male , Female , HIV/pathogenicity , T-Lymphocytes , Antitubercular Agents
2.
JMS-Journal of Medical Sciences. 1994; 3 (4): 37-9
in English
| IMEMR
| ID: emr-32682